Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine
- 16 April 2010
- journal article
- research article
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 29 (2) , 217-230
Abstract
Gender, a biological determinant of mental health and illness, plays a critical role in determining patients' susceptibility, exposure to mental health risks, and related outcomes. Regarding sex differences in the epidemiology of opioid dependence, one third of the patients are women of childbearing age. Women have an earlier age of initiation of substance use and a more rapid progression to drug involvement and dependence than men. Generally few studies exist which focus on the special needs of women in opioid maintenance therapy. The aim of this paper is to provide an overview of treatment options for opioid-dependent women, with a special focus on buprenorphine, and to look at recent findings related to other factors that should be taken into consideration in optimizing the treatment of opioid-dependent women. Issues addressed include the role of gender in the choice of medication assisted treatment, sex differences in pharmacodynamics and pharmacokinetics of buprenorphine drug interactions, cardiac interactions, induction of buprenorphine in pregnant patients, the neonatal abstinence syndrome and breastfeeding. This paper aims to heighten the awareness for the need to take gender into consideration when making treatment decisions in an effort to optimize services and enhance the quality of life of women suffering from substance abuse.Keywords
This publication has 97 references indexed in Scilit:
- The effect of methadone maintenance on positive outcomes for opiate injection drug usersJournal of Substance Abuse Treatment, 2009
- Treatment of opioid-dependent pregnant women: Clinical and research issuesJournal of Substance Abuse Treatment, 2008
- Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of CopenhagenHeart, 2007
- Management of neonatal abstinence syndrome in neonates born to opioid maintained womenDrug and Alcohol Dependence, 2007
- Incidence and risk factors for hepatitis C seroconversion in injecting drug users in AustraliaAddiction, 2006
- Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatmentDrug and Alcohol Dependence, 2004
- Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic DepressionAmerican Journal of Psychiatry, 2000
- Gender Effects in Pharmacokinetics and PharmacodynamicsDrugs, 1995
- The Prevalence of Illicit-Drug or Alcohol Use during Pregnancy and Discrepancies in Mandatory Reporting in Pinellas County, FloridaNew England Journal of Medicine, 1990
- A study of factors that influence the severity of neonatal narcotic withdrawalThe Journal of Pediatrics, 1976